Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

2010-12-01 08:18:22

(Ivanhoe Newswire) -- Nonmelanoma skin cancers are some of the most commonly diagnosed in the U.S. A new study found a possible preventative treatment in the nonsteroidal, anti-inflammatory drug Celecoxib. Celecoxib is typically used to inhibit the enzyme cyclooxygenase 2, which has been associated with the onset of UV ray-caused nonmelanoma skin cancers.  Since sunscreen has only shown mediocre results in protecting reducing these cancers, researchers at the University of Alabama at...

2010-11-30 21:58:02

New research shows the NSAID Celebrex may help prevent some non-melanoma skin cancers from developing in patients who have pre-cancerous actinic keratoses lesions and are at high risk for having the disease. The researchers, led by University of Alabama at Birmingham senior scientist and the study's lead author, Craig Elmets, M.D., co-leader of the UAB Comprehensive Cancer Center 's Chemoprevention Program, evaluated the efficacy and safety of celecoxib as a chemo-preventive agent for actinic...

2010-11-18 08:02:00

WASHINGTON, Nov. 18, 2010 /PRNewswire/ -- Comedienne, television host, author and mother Joy Behar, and her daughter Eve, will be honored at AARP The Magazine's 2011 Inspire Awards gala on December 9 in Washington, D.C. for a public awareness campaign aimed at urging women -- who are less likely than men to survive a heart attack(i) -- to be prepared if heart attack strikes without warning. AARP The Magazine's Inspire Awards recognize people who have inspired others to action through...

2010-11-17 06:30:00

IRVINE, Calif., Nov. 17, 2010 /PRNewswire/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced the U.S. Food and Drug Administration (FDA) has granted the Company three years of marketing exclusivity for BROMDAY(TM) (bromfenac ophthalmic solution) 0.09%, as provided under the Drug Price Competition and Patent Term Restoration Act, commonly known as the Hatch-Waxman Act. BROMDAY (formerly referred to as XiDay), the first and only once-daily prescription eye drop for the treatment...

2010-11-16 07:30:00

BEDMINSTER, N.J., and MILTON, Canada, Nov. 16, 2010 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, and Tribute Pharmaceuticals, a privately-held Canadian specialty pharmaceutical company, announced today their exclusive license agreement for the commercialization of CAMBIA(TM) (diclofenac potassium for oral solution) in Canada. CAMBIA(TM) is approved in the United States for the acute treatment of migraine with or without aura and was...

2010-11-10 17:40:00

NEW YORK, Nov. 10, 2010 /PRNewswire/ -- Aspirin comes to the rescue again, as a potential prostate cancer treatment option. A new study presented at the American Society for Radiation Oncology (ASTRO) in San Diego, shows that it may cut the risk of dying for men with prostate cancer that has not spread beyond the prostate gland. "The study showed that prostate cancer patients taking blood thinning, or anticoagulant medication, specifically aspirin, had a lower risk of mortality, more so in...

2010-11-01 22:37:52

Nonsteroidal anti-inflammatory drugs (NSAIDs) prevent colon cancer by triggering diseased stem cells to self-destruct, according to researchers at the University of Pittsburgh Cancer Institute (UPCI) and the University of Pittsburgh School of Medicine. Their findings, reported in the early online version of this week's Proceedings of the National Academy of Sciences, could lead to new strategies to protect people at high risk for the disease. Doctors have long known that NSAIDs, such as...

2010-10-26 07:30:00

BEDMINSTER, N.J., Oct. 26 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company, announced today that an analysis of two pivotal safety and efficacy studies of CAMBIA(TM) (diclofenac potassium for oral solution) will be presented at the 4th World Congress on Controversies in Neurology Conference (CONy) in Barcelona, Spain. The new analysis will be presented in a poster (#23) entitled, "Rapid and Sustained Improvement in Migraine Symptoms with a...

ebdedcb4a1c30ddeb29f3174c5341d871
2010-10-22 09:15:00

The same low dose aspirin recommended by doctors to lower the risk of heart attack and stroke can also help combat colon cancer, according to new researched published Friday in The Lancet. An international team of researchers, led by Oxford University Professor Peter M. Rothwell, conducted a series of four randomized trials over a total period of 20 years. Each of the studies lasted an average of six years and involved a total of more than 14,000 patients, who either took a placebo or one of...

2010-10-07 14:17:00

NASHVILLE, Tenn., Oct. 7 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data affirming the safety and efficacy of Caldolor® (ibuprofen) Injection in treating fever in critically ill and non-critically ill adults. Published in the peer-reviewed journal Critical Care, the study showed that IV ibuprofen was significantly more effective at reducing fever in hospitalized patients than placebo. "These findings demonstrate...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related